| IFN-γ-induced TNF-α expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages V Sol, C Punzon, M Fresno The Journal of Immunology 181 (7), 4461-4470, 2008 | 191 | 2008 |
| Myeloid‐derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis V Moliné‐Velázquez, H Cuervo, V Vila‐del Sol, MC Ortega, D Clemente, ... Brain Pathology 21 (6), 678-691, 2011 | 132 | 2011 |
| Involvement of TNF and NF-κB in the transcriptional control of cyclooxygenase-2 expression by IFN-γ in macrophages V Sol, M Fresno The Journal of Immunology 174 (5), 2825-2833, 2005 | 99 | 2005 |
| Requirement of tumor necrosis factor α and nuclear factor-κB in the induction by IFN-γ of inducible nitric oxide synthase in macrophages V Vila-del Sol, MD Díaz-Muñoz, M Fresno Journal of Leucocyte Biology 81 (1), 272-283, 2007 | 95 | 2007 |
| TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury JM Rosa, V Farré‐Alins, MC Ortega, M Navarrete, AB Lopez‐Rodriguez, ... British journal of pharmacology 178 (17), 3395-3413, 2021 | 62 | 2021 |
| The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway AG Granja, ML Nogal, C Hurtado, V Vila, AL Carrascosa, ML Salas, ... Journal of Biological Chemistry 279 (51), 53736-53746, 2004 | 57 | 2004 |
| The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability V Moliné-Velázquez, MC Ortega, VV del Sol, C Melero-Jerez, F de Castro, ... Neurobiology of disease 67, 149-164, 2014 | 36 | 2014 |
| Expression of early growth response gene-2 and regulated cytokines correlates with recovery from Guillain–Barré syndrome E Doncel-Pérez, L Mateos-Hernández, E Pareja, Á García-Forcada, ... The Journal of Immunology 196 (3), 1102-1107, 2016 | 20 | 2016 |
| Myeloid cell distribution and activity in multiple sclerosis V Moline-Velazquez, V Sol, F de Castro, D Clemente Universidad de Murcia. Departamento de Biología Celular e Histología, 2016 | 17 | 2016 |
| Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis MC Ortega, R Lebrón-Galán, I Machín-Díaz, M Naughton, I Pérez-Molina, ... Acta Neuropathologica 146 (2), 263-282, 2023 | 12 | 2023 |
| Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses P Hélie, C Camacho-Toledano, L Lesec, C Seillier, AJ Miralles, ... Journal of neuroinflammation 18, 1-17, 2021 | 10 | 2021 |
| Cellular and molecular processes are differently influenced in primary neural cells by slight changes in the physicochemical properties of multicore magnetic nanoparticles E Benayas, A Espinosa, MT Portolés, V Vila-del Sol, MP Morales, ... ACS Applied Materials & Interfaces 15 (14), 17726-17741, 2023 | 8 | 2023 |
| Myeloid-derived suppressor cells are key elements for symptom recovery in a murine model of multiple sclerosis V Moliné-Velázquez, MC Ortega, V Vila-del Sol, C Melero-Jerez, ... Journal of Neuroimmunology 275 (1), 83, 2014 | 2 | 2014 |
| Myeloid-Derived Suppressor Cells are relevant factors to predict the severity of multiple sclerosis MC Ortega, R Lebrón-Galán, I Machín-Díaz, M Naughton, I Pérez-Molina, ... bioRxiv, 2022.04. 20.488896, 2022 | 1 | 2022 |
| Detection of Monocytic Myeloid-Derived Suppressor Cells in the Human Brain and Blood MC Ortega, V Vila-del Sol, I Machín-Díaz, D Clemente Neural Stem Cells: Methods and Protocols, 89-109, 2025 | | 2025 |
| Circulating monocytic myeloid-derived suppressor cells but not Treg are potential biomarkers of a full relapse recovery in untreated multiple sclerosis patients LC Melero, I Machin-Diaz, I Alonso-Garcia, IP Molina, ... MULTIPLE SCLEROSIS JOURNAL 29, 562-563, 2023 | | 2023 |
| MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS MC Ortega, I Machin-Diaz, M Naughton, I Pérez-Molina, J García-Arocha, ... IBRO Neuroscience Reports 15, S285-S286, 2023 | | 2023 |
| Dataset of the publication “Cellular and Molecular Processes Are Differently Influenced in Primary Neural Cells by Slight Changes in the Physicochemical Properties of Multicore … E Benayas, A Espinosa, MT Portolés, V Vila-del Sol, MP Morales, ... https://doi. org/10.1021/acsami. 3c02729, 2023 | | 2023 |
| Circulating myeloid-derived suppressor cells as a potential biomarker of an anti-inflammatory T-cell balance associated with improved relapse recovery in multiple sclerosis L Calahorra, I Machin-Diaz, I Alonso, I Perez-Molina, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 829-829, 2022 | | 2022 |
| Study of alternative suppressor mechanisms of the immune response in a multiple sclerosis animal model V Vila-del Sol, D Clemente, MC Ortega, JA Perez-Simon, F de Castro JOURNAL OF NEUROIMMUNOLOGY 197 (2), 174-174, 2008 | | 2008 |
